Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Cancers 2011, 3(4), 4245-4257; doi:10.3390/cancers3044245
Review

Stroma-Directed Molecular Targeted Therapy in Gastric Cancer

* ,
 and
Received: 11 October 2011; in revised form: 22 November 2011 / Accepted: 30 November 2011 / Published: 8 December 2011
(This article belongs to the Special Issue Tumor Stroma)
View Full-Text   |   Download PDF [856 KB, uploaded 8 December 2011]   |   Browse Figures
Abstract: Recent studies in molecular and cellular biology have shown that tumor growth and metastasis are not determined by cancer cells alone, but also by a variety of stromal cells. Tumor stroma contains abundant extracellular matrix and several types of cells, including carcinoma-associated fibroblasts (CAFs), endothelial cells, pericytes and inflammatory cells including macrophages. In gastric cancer tissues, tumor cells express platelet-derived growth factor (PDGF)-B. Stromal cells, including CAFs, pericytes and lymphatic endothelial cells, express PDGF receptor (PDGFR)-β. Administration of PDGFR tyrosine kinase inhibitor significantly decreases stromal reaction, lymphatic vessel area and pericyte coverage of tumor microvessels. Administration of PDGFR tyrosine kinase inhibitor in combination with cytotoxic chemotherapeutic drug(s) impairs the progressive growth and metastasis of gastric cancer. Activated stroma might serve as a novel therapeutic target in cases of gastric cancer.
Keywords: gastric cancer; stroma; platelet-derived growth factor receptor (PDGFR); carcinoma-associated fibroblast (CAF) gastric cancer; stroma; platelet-derived growth factor receptor (PDGFR); carcinoma-associated fibroblast (CAF)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kitadai, Y.; Kodama, M.; Shinagawa, K. Stroma-Directed Molecular Targeted Therapy in Gastric Cancer. Cancers 2011, 3, 4245-4257.

AMA Style

Kitadai Y, Kodama M, Shinagawa K. Stroma-Directed Molecular Targeted Therapy in Gastric Cancer. Cancers. 2011; 3(4):4245-4257.

Chicago/Turabian Style

Kitadai, Yasuhiko; Kodama, Michiyo; Shinagawa, Kei. 2011. "Stroma-Directed Molecular Targeted Therapy in Gastric Cancer." Cancers 3, no. 4: 4245-4257.



Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert